LC-MS/MS-Based Quantitative Analysis of Drug Metabolites for Pharmacokinetic and Bioavailability Studies: A Comprehensive Review

Abstract

ABSTRACT Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) has established itself as the gold standard methodology for the precise, selective, and high-throughput quantitative determination of drugs and their active or inactive metabolites in complex biological matrices. In modern drug discovery and development, comprehensive pharmacokinetic (PK) and bioavailability evaluations require bioanalytical assays capable of delineating subtle structural modifications, sub-nanogram per milliliter detection limits, and minimal matrix interferences. This review provides a rigorous, state-of-the-art analysis of LC-MS/MS-based bioanalysis, detailing ion source thermodynamics, mass analyzer architectures (triple quadrupole, Q-ToF, Orbitrap), sample preparation methodologies (protein precipitation, liquid liquid extraction, solid-phase extraction), and chromatographic separation strategies (reversed-phase, HILIC, sub-2 µm core-shell columns). We evaluate the critical bioanalytical parameters governing assay validation in accordance with international FDA, EMA, and ICH M10 guidelines, emphasizing matrix effect mitigation, internal standard selection, carryover control, and systemic stability assessments. Furthermore, the role of LC MS/MS in characterizing phase I and phase II metabolic transformations, metabolite-mediated toxicity, reactive intermediate trapping, and absolute oral bioavailability is critically interrogated. Strategic translational innovations—including micro-sampling approaches (DBS, VAMS), high resolution mass qualitative/quantitative spectrometry profiling, (HRMS) and for automated simultaneous high-throughput workflows—are benchmarked. Ultimately, this review synthesizes key bioanalytical challenges and outlines future directions toward AI-integrated bioanalysis and ultra-trace clinical pharmacokinetic monitoring.

KEYWORDS: LC-MS/MS; Pharmacokinetics; Bioavailability; Drug Metabolite Quantification; Bioanalytical Method Validation; Electrospray Ionization; Matrix Effect; Mass Spectrometry.